The objective of this study is to examine the association of hs-CRP levels with the occurrence of ischemic stroke among patients with nonalcoholic fatty liver disease, after adjusting for potential confounding factors. Here, CRP is linked to metabolic dysfunction-associated steatotic liver disease.